High volatility in Moderna Inc. stock price on Tuesday which ended trading at $307.33

The Moderna Inc. stock price fell by -2.00% on the last day (Tuesday, 20th Jul 2021) from $313.59 to $307.33. During the day the stock fluctuated 17.30% from a day low at $292.00 to a day high of $342.51. The price has risen in 7 of the last 10 days and is up by 31.71% over the past 2 weeks. Volume has increased on the last day by 74 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 109 million shares were bought and sold for approximately $33.63 billion.

On July 15, 2021 "Jefferies Financial Group" gave "$170.00 - $250.00" rating for MRNA. The price target was set to $247.50+0.3%.Over the last 30 days, this security got 2 buy, 0 sell, and 0 hold ratings.

The stock lies in the upper part of a very wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $315.33 will firstly indicate a stronger rate of rising.Given the current short-term trend, the stock is expected to rise 52.13% during the next 3 months and, with a 90% probability hold a price between $349.96 and $479.72 at the end of this 3-month period.

The Moderna Inc. stock holds buy signals from both short and long-term moving averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $269.74 and $226.41. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 months Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 19, 2021, and so far it has fallen -2.00%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

On the downside, the stock finds support just below today's level from accumulated volume at $286.43 and $259.68.There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Moderna Inc. finds support just below today's level at $286.43. If this is broken, then the next support from accumulated volume will be at $259.68 and $234.46.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $50.51 between high and low, or 17.30%. For the last week, the stock has had a daily average volatility of 9.54%.

The Moderna Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Moderna Inc. stock to perform well in the short-term.We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.